Doug Weber holds the Akhtar and Bhutta Professorship at Carnegie Mellon, where his research focuses on sensory feedback and restoring function after stroke, spinal cord injury, and limb loss, and he was a founding member of DARPA's Biological Technologies Office, where he created and ran major neurotechnology programs like HAPTIX, ElectRx, and TNT. He holds eight U.S. patents related to using the nervous system to control prosthetics and machines, and his expertise has led to him being cited in coverage of Neuralink's first clinical trial, Meta's wristband interface, and new paralysis treatments.